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Important functions in myogenesis have been proposed for FGF6, a member of the fibroblast growth factor family accumulating almost
exclusively in the myogenic lineage. However, the analyses of Fgf6 (−/−) mutant mice gave contradictory results and the role of FGF6 during
myogenesis remained largely unclear. Recent reports support the concept that FGF6 has a dual function in muscle regeneration, stimulating
myoblast proliferation/migration and muscle differentiation/hypertrophy in a dose-dependent manner. The alternative use of distinct signaling
pathways recruiting either FGFR1 or FGFR4 might explain the dual role of FGF6 in myogenesis. A role for FGF6 in the maintenance of a reserve
pool of progenitor cells in the skeletal muscle has been also strongly suggested. The aim of this review is to summarize our knowledge on the
involvement of FGF6 in myogenesis.
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Fibroblast growth factors (FGFs) make up a large family of
polypeptide growth factors that have diverse roles, during
embryonic development, in regulating cell proliferation,
migration and differentiation [1]. In the adult organism,
FGFs are homeostatic factors and function in tissue repair and
response to injury [1]. The FGFs transduce their signals to the
cell through transmembrane tyrosine kinase receptors (FGFRs)
for which four distinct genes have been discovered (FGFR1–
FGFR4) [2]. Among the FGF family members, FGF6 exhibits
a restricted expression profile predominantly in the myogenic
lineage in adult and developing skeletal muscle [3,4],
suggesting that it may be a component of signaling events
associated with somite formation [5] and the regeneration
process of the adult muscle [6]. To better understand the
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different laboratories and skeletal muscle regeneration has
been studied in these FGF6 (−/−) mice, giving rise to
contradictory results [7–9]. However, recent reports begin to
depict the functional involvement of FGF6 in muscle
construction, propose a model accounting for the specific
role of FGF6 in muscle regeneration [10] and resolve the
apparent contradiction of the results from the two FGF6 knock
out mice [7,8]. The aim of this review is to summarize our
knowledge on the role of FGF6 in myogenesis.
1.1. FGF6 gene: structure and expression
In mice, the sixth member of the fibroblast growth factor
gene family is composed of three coding exons and encodes a
putative growth protein of 208 amino acid residues, possessing
a potential signal peptide and presenting 93.5% sequence
similarity with the human FGF6 gene product. The murine Fgf6
gene is located in a region distinct from the Int41 locus and
belongs to a linkage group conserved between chromosome 12
in man and chromosome 6 in mouse [11]. Comparative
genomics on the mammalian Fgf6 locus revealed that human,
rat and mouse FGF6 promoters are highly conserved [12].
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FGF gene family, and particularly to the Fgf4 gene product. It is
expressed as a 4.8 kb transcript in skeletal muscle [13]. Only a
hybrid growth factor containing features characteristic of both
FGF4 and FGF6 has been identified in frogs and chickens,
suggesting that the step of duplication which created FGF4 and
FGF6 took place with the emergence of mammals. However, in
the trout, a genomic FGF6 clone composed of three exons
encoding a putative protein of 206 amino acids and showing
64.6 and 63.6% similarity with mouse and human FGF6,
respectively, and only 46.5% similarity with mouse and human
FGF4 has been isolated [14]. More recently, a cDNA sequence
encoding sea bass (Dicentrarchus labrax) FGF6 (209 amino
acids) has been isolated and shows a high sequence identity
with other teleost and mammalian FGF6s [15].
In situ hybridization indicated that Fgf6 expression is
restricted to developing skeletal muscle. In mice, Fgf6
transcripts were first detected in embryos at E9.5 and were
localized exclusively in the myotomal compartment of the
somites. At E12.5, FGF6 expression was still detected in the
myotome, and also in the region containing the developing
muscles of the body wall. Its expression remains in developing
skeletal muscles up to at least 16.5 days post-conceptus [3,4]. In
the adult rat, FGF6 protein seems selectively expressed in the
fast-type muscles [16]. In the trout, FGF6 transcripts were
detected in fast-twitch and to a lesser extent in slow-twitch
myofibers [14]. The prolonged phase of muscle fiber hyper-
plasia which occurs in trout is accompanied by the lasting
expression of FGF6 up to the adult stage, suggesting that FGF6
may participate in the continuous generation of muscle fibers
within the myotomal musculature of post-larval animals. FGF6
transcripts and protein were also transiently up-regulated after
muscle injuries in fast as well as slow muscles [7,17]. During
muscle regeneration, Zhao and Hoffman [18] suggest that FGF6
is released from necrotic myofibers, where it is then sequestered
by basal laminae. The expression pattern of FGF6 supported the
concept that this particular growth factor could play an
important role in myogenesis.
1.2. FGF6 and its receptors
Numerous FGFs, other than FGF6, are also expressed in
skeletal muscle, including FGF2 [19], FGF5 [20] and FGF7
[21]. Many of these FGFs, like many other growth factors, have
been shown to induce myoblast proliferation in vitro [22].
FGF1, FGF4, FGF2 and FGF6 enhance satellite cell prolifera-
tion to a similar degree, whereas FGF5 and FGF7 are ineffective
[23]. However, as has been also shown for IGF-I, FGF6 is
involved in proliferation as well as in differentiation of the
myogenic lineage [6]. Exogenous FGF6 at low or high
concentrations respectively stimulates the proliferation of C2
myoblasts and delayed differentiation into myotubes or
increased the expression of muscle cell differentiation markers
[6]. High levels of FGF6 provided by gene transfer, also
repressed myogenic determinants in C2C12 myogenic cells and
precluded myotube formation [24]. Armand et al. [17] showed
that a single injection of FGF6 in regenerating soleus of adultmice has a biphasic effect, first involving proliferation
characterized by an up-regulation of cyclin D1, followed by
an increase of differentiation markers (such as CdkIs, MHCI
and TnI) and an acceleration of cellular differentiation.
The four known FGF receptors, FGFR1 through FGFR4,
share between 55% and 72% identity at the protein level [25].
FGF6 induces a transduction signal, preferentially via FGFR1
and FGFR4 as reported by binding studies between the different
FGFs and their FGFRs [26,27]. Mutations in growth factor
receptors expressed in skeletal muscle resulted either in early
embryonic lethality (FGFR1) [28–30], thereby preventing
analysis of their functions in muscle cells, or in no apparent
phenotypic alterations of muscle development and its main-
tenance (FGFR4) [31]. In vivo as well as in vitro, high
concentrations of recombinant FGF6 up-regulated and down-
regulated the expression of FGFR1 and FGFR4 respectively,
supporting the idea that FGF6 is involved in the control of the two
specific phases of myogenesis, i.e. proliferation and differentia-
tion, depending on concentration and alternative receptor usage.
In vitro analysis indicated that both FGF6 and FGFR4 were
uniquely expressed by myofibers and satellite cells, whereas
FGFR1 was ubiquitously expressed by myogenic and nonmyo-
genic cells [23]. FGF receptors have different signaling and
mitogenic potentials [32,33]. In cultured skeletal muscle satellite
cells, it has been shown that FGFR1 is required for proliferation
and represses differentiation via the ERK1/2 signaling cascade
[34]. In contrast, in vivo inhibition of FGFR4 signal resulted in an
arrest of muscle progenitor differentiation [35]. During muscle
regeneration, the pro-differentiation FGFR4 pathway was
transiently expressed at day 3, commensurate with expression
ofMyoD,Myogenin, Myf5, and Pax7. FGFR4 protein is strongly
expressed in differentiating myoblasts and newly formed
myotubes, suggesting that FGFR4 is likely the key receptor for
FGF6 during muscle regeneration [18].
1.3. Gene knock out mice
The expression pattern of FGF6 supported the concept that
this particular growth factor could play an important role in
myogenesis. To test this, mice with a homozygous disruption of
the FGF6 gene have been generated in two laboratories [7–9].
The mutant animals were viable, fertile and apparently had
normal skeletal muscle formation. Floss et al. [7], using light
and electronic microscopy as well as immunohistochemical
stainings with antibodies directed against MHC, actin, titin and
desmin, found no significant differences between Fgf6(−/−)
and wild type mice. In contrast, the same authors indicated that
Fgf6(−/−) mutant mice showed a severe regeneration defect
with fibrosis and myotube degeneration following a freeze-
crush injury. The numbers of MyoD- and myogenin-expressing
activated satellite cells after injury were significantly reduced
in mutants, presumably due to a lack of activation or
proliferation of quiescent satellite cells. Interbreeding of Fgf6
(−/−) mutants with mdx mice leads to striking dystrophic
changes in skeletal muscles of double homozygous mice
characterized by myotube degeneration, the presence of large
numbers of mononuclear cells, and deposition of collagen.
775A.-S. Armand et al. / Biochimica et Biophysica Acta 1763 (2006) 773–778RNA analysis revealed an up-regulation of MyoD mRNA in
mdx but not in Fgf6(−/−)/mdx−/− double mutant mice.
In contrast, in the report of Fiore et al. [8], where muscle
degeneration was induced by notexin drug or crush injury, the
defect in FGF6 expression apparently did not modify the kinetics
of muscle regeneration. Following the breeding Fgf6 −/− mice
with mdx dystrophin deficient mice, the Fgf6 −/−:mdx and mdx
muscles were similar, suggesting that FGF6 is not involved in
muscle regeneration, i.e., in satellite cell proliferation and fusion,
or that its role is strictly compensated by other factors, possibly
other FGFs. To explain the differences observed between the two
models of mice lacking FGF6 [36], different hypotheses were
suggested. First, variations in the expression of compensating
FGF genes in different genetic backgrounds [37] might
contribute to the difficulties in detecting a major role of FGF6
in muscle regeneration. Another possible explanation for
differences in the phenotype is the presence or absence of
additional modifier genes or the different design of the targeted
mutation, which might lead to considerable differences in the
observed phenotypes [38]. In addition, even in a uniform genetic
background, stochastic variations in the expression of a
regulatory circuit can result in dramatic differences in pheno-
typic consequences [39].
1.4. FGF6 and muscle stem cells
Different analyses support the idea that FGF6 and FGF2
could have some common properties in the control of
myogenesis [17,40–42]. Targeted transgene delivery of FGF2
and FGF6 enhanced muscle repair and FGF gene-treated
wounds showed on average of a 20-fold increase of regenerat-
ing myotubes expressing the marker CD56 versus untreated
controls [42] In fact, FGF2 (and FGF4) and more recently
FGF6 have been shown to stimulate the migration of myogenic
stem cells in vitro and in vivo [36,43,44]. In this respect [36],
indicated that FGF6 deficient mutant myoblasts displayed a
decreased migration ability in vivo. The use of dominant-
negative retroviruses for RAS and RAL led these last authors to
propose that FGFs (FGF2 and FGF6) support the migration of
myoblasts probably through a Ras-/Ral-dependent signaling
pathway. In vitro, the reduced ability of FGF2 and FGF6
mutant myoblasts to migrate can be rescued to some extent by
the addition of supraphysiological concentrations of either
FGF2 or FGF6, indicating that both growth factors might
partially compensate for each other. However, Israeli et al. [24]
establish a new undescribed link between FGF6 and a
multidrug resistance gene expressed in stem cells, suggesting
a role for FGF6 in the maintenance of a reserve pool of
progenitor cells in the skeletal muscle. Indeed using fluores-
cence-activated cell sorting (FACS), the authors showed that
the side population (SP) fraction present in the C2C12 line was
greatly increased by FGF6 provided by gene transfer.
Expansion of the pool of cells with SP phenotype was
correlated with the up-regulation of the mdr1a multidrug
resistance gene, which encodes a toxin efflux pump consis-
tently found in stem cells [45]. With the use of microarray
technology, the same group [46] identified genes involved inthe FGF6 cell response. In particular, the up-regulation of
FGFR1 and the down-regulation of FGFR4 were observed,
corroborating the proliferative phenotype of the C2C12 cells
and their dedifferentiation in the presence of high levels of
FGF6 previously reported [6,17]. These results show that FGF6
pushed committed myogenic cells toward a more immature
phenotype, resulting in the accumulation of cells with a SP
phenotype and suggesting that FGF6 conditioning could
provide a way to expand the pool of immature cells by
myoblast dedifferentiation.
1.5. Muscle differentiation and muscle phenotype
Histological analysis of regenerating muscle from Fgf6 (−/−)
mice generated by Fiore et al. [8] revealed an earlier detection
of myotubes following cardiotoxin injection in comparison to
wild type mice [10]. This acceleration of the cellular
differentiation process in regenerating muscles of the mutant
mice was correlated with an increase in the expression of
markers of differentiation (CdkIs like p16 and p21, as well as
calcineurin or myogenin) and of structural proteins (MHCI and
slow TnI), along with the up-regulation of calcineurin A
phosphatase activity. Calcineurin is a Ca2+/calmodulin-
dependent protein serine/threonine phosphatase involved in
skeletal muscle growth and differentiation. Calcineurin phos-
phatase activity is required for the initiation of skeletal muscle
cell differentiation in culture [47], for the stimulation of slow
muscle gene promoters, and for slow fiber differentiation both
in culture and in vivo [48,49]. Similarly, we showed an
increase in the number of slow oxidative (type I) myofibers
and a corresponding decrease in the number of fast oxidative
(type IIa) myofibers in both regenerating and adult soleus of
Fgf6 (−/−) mice. The rescue experiments by injection of
rhFGF6 confirmed the regulating role of FGF6 on the
calcineurin signaling pathway and indicated that the accumula-
tion of both calcineurin and cyclin D1 transcripts was subject
to an opposite dose-dependent regulation by FGF6 [10]. The
calcineurin signaling pathway is involved in the nerve-activity-
dependent induction and maintenance of fiber-type-specific
gene programs [48,50], but our results strongly supported the
hypothesis that the lack of FGF6 is responsible for the
precocious and nerve-independent up-regulation of calcineurin
activity in FGF6-deficient mutant mice [10]. This early
stimulation of calcineurin triggers the induction of the slow
phenotype muscle gene program. Following that, tonic
innervation takes place, permitting the maintenance of the
slow phenotype detected in myofibers in regenerating and
adult soleus by the induction of a second wave of calcineurin
activation observed from 2 weeks after cardiotoxin injury in
regenerating soleus. The transient accumulation of FGF6
during soleus regeneration influences both muscle differentia-
tion and myofiber type switching, acting on both calcineurin
accumulation and calcineurin activity. On the other hand, the
overexpression of IGF-II observed in Fgf6 mutant mice [51]
could be substantially involved in the differentiation process
during muscle regeneration of Fgf6 (−/−) mice since it is
known that IGF-II promotes muscle differentiation [52].
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In regenerating soleus of the Fgf6 (−/−) mice, myofibers
were hypertrophied as compared to wild-type mice [51].
IGF-II, one of the members of the insulin-like growth factor
family, could play a crucial role in myofiber hypertrophy of
this mutant mouse. The members of the insulin-like growth
factor family (IGF-I and IGF-II) are known to be important
in the regulation of myogenesis. These growth factors
enhance both satellite cell proliferation and differentiation
in vitro [52]. Moreover, IGF-I is able to stimulate muscle
hypertrophy (increase in protein content and size of
myofibers) during muscle regeneration [rev. in 53]. IGFs
elicit their effects through binding to the type I IGF receptor
(IGF1R), which is part of a tyrosine kinase signaling
pathway [54]. The structurally distinct IGF-II receptor
(IGF2R)/mannose 6-phosphate receptor lacks tyrosine kinase
activity [55] and has been shown to be involved in the
degradation of IGF-II [56]. In regenerating muscle of the
Fgf6 (−/−) mice, both IGF-II and IGF2R (at the transcriptFig. 1. Roles of FGF6 in muscle regeneration. Following muscle injury, the transient
myogenic progenitor cells but also pushes committed myogenic cells toward a more
dose-dependent manner, both muscle differentiation and muscle phenotype via a nerv
II/IGF2R pathway [51]. This early stimulation of calcineurin triggers the induction
regulated the expression of FGFR1 and FGFR4 respectively, possibly accounting
differentiation), depending on concentration and alternative receptor usage [6,17].and protein levels), but not IGF-I and IGF1R, were strongly
up-regulated. This observation suggests that, in the absence
of FGF6, the mechanisms leading to myofiber hypertrophy
were mediated specifically by an IGF-II/IGF2R signaling
pathway distinct from the classic mechanism involving IGF-I
and IGF1R previously described as regulating skeletal
muscle hypertrophy. However, although numerous reports
have indicated that the overexpression of IGF-I induces
hypertrophic muscle cells [53], the extent of involvement of
IGF-II in the skeletal muscle hypertrophy process remains
unknown, whereas both IGF-I and IGF-II rapidly and
directly induce hypertrophic growth in cultured adult rat
ventricular cardiomyocytes [57]. Several reports have
indicated that IGF2R signaling occurs through a G-protein-
coupled pathway that leads to activation of mitogen-activated
protein kinase (MAPK) [58]. Another major player in the
control of muscle fiber size is myostatin since when the
myostatin gene was disrupted, skeletal muscle mass
significantly increased, up to three times normal [59]. In
adult myostatin (−/−) mutant mice, IGF-II was alsoup-regulation of FGF6 stimulates both the proliferation and migration [36] of the
immature phenotype [26,44]. Secondly, the fall of muscle FGF6 regulates, in a
e-independent signaling calcineurin pathway [10], and myofiber size via an IGF-
of the slow phenotype muscle gene program. FGF6 up-regulated and down-
for biphasic effects of FGF6 on muscle regeneration (i.e. proliferation and
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IGF-I in adult soleus of these mice was identical to that in
wild-type mice [60] suggesting a physiological process
whereby IGF-II is the key relay inducing hypertrophy.
1.7. Conclusion and perspectives
From our results and from those of others, we propose
here a model accounting for the specific role of FGF6 in
muscle regeneration (Fig. 1) that emphasizes the dose-
dependent effects of this particular growth factor. Following
muscle injury, the transient up-regulation of FGF6 stimulates
several cellular events, such as the proliferation and migration
of the myogenic stem cells [36] but also controls the
maintenance of a reserve pool of progenitor cells in muscle
[24,46]. Secondly, FGF6 regulates, in a dose-dependent
manner, both muscle differentiation and muscle phenotype
via a signaling calcineurin pathway [10] and myofiber size
via an IGF-II/IGF2R pathway [51]. This last point should be
submitted to extensive investigations since a recent analysis
indicated that the hypertrophy of myofibers in mice lacking
FGF6 could be also dependent on the type of myofibers (i.e.,
fast versus slow) (Laziz, unpublished result). Future analysis
should be addressed to evaluating the functional properties of
muscles from mice lacking FGF6. The previous reports
allowed a better understanding of the cellular and molecular
characteristics of the Fgf6(−/−) muscle cells, but nothing is
known about the functional properties of Fgf6 (−/−) muscles.
However, preliminary results (Laziz, unpublished results)
supported the idea of a more important muscle weakness in
Fgf6(−/−) mice in comparison to wild mice. Indeed,
following an eccentric race exercise, an increased number
of necrosis loci were detected in regenerated muscle of the
mutant versus wild type mice suggesting an impaired
resistance to mechanical stress of regenerated skeletal muscle
from FGF6 deficient mice. This should be now confirmed by
further investigations concerning contractile parameters and
notably the maximal titanic strength of the Fgf6(−/−)
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